CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $58,368,000 | +100.7% | 634,718 | +91.8% | 0.03% | +8.3% |
| Q2 2015 | $29,082,000 | +19.4% | 330,929 | +0.8% | 0.02% | +20.0% |
| Q1 2015 | $24,366,000 | -13.7% | 328,253 | -34.9% | 0.02% | -16.7% |
| Q4 2014 | $28,231,000 | +153.5% | 504,123 | +87.4% | 0.02% | +140.0% |
| Q2 2014 | $11,138,000 | -36.1% | 268,977 | +6.8% | 0.01% | -37.5% |
| Q1 2014 | $17,441,000 | +60.3% | 251,789 | +39.5% | 0.02% | +60.0% |
| Q4 2013 | $10,880,000 | +13.3% | 180,529 | +14.2% | 0.01% | 0.0% |
| Q3 2013 | $9,607,000 | +23.5% | 158,065 | +36.0% | 0.01% | +25.0% |
| Q2 2013 | $7,782,000 | – | 116,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |